Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 932 trades; $2B in total
Open-market sales: 1,042 trades; $2.3B in total
Insiders filing: 464 insiders; Last 7 days
Companies with several buyers: 26; Last 7 days

		Trade type
Beth C. SeidenbergDirector	Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
Westlake BioPartners Fund I10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
Westlake BioPartners Opportunity GP I10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
Westlake BioPartners Opportunity Fund I10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
Westlake BioPartners GP I10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
Karen Marie WalkerCTO	Kyverna TherapeuticsKYTX	Open-market sale10b5-1 plan	25/12/15	25/12/17	23,998 sh	$12.20	$292,775.6	−51.5%
Bain Capital Life Sciences Investors10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	253,136 sh2 trades	$22.00avg.	$5,568,992	No record
10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	253,136 sh2 trades	$22.00avg.	$5,568,992	No record
10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	253,136 sh2 trades	$22.00avg.	$5,568,992	No record
10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	253,136 sh2 trades	$22.00avg.	$5,568,992	No record
Bain Capital Life Sciences Fund III10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
Bain Capital Life Sciences Opportunities III10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
Bain Capital Life Sciences III General Partner10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
Bain Capital Life Sciences Opportunities III GP10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
Gilead Sciences10% Owner	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/13	910,000 sh	$22.00	$20,020,000	+28.3%
Michael P. RubinOther	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/12	450,000 sh	$22.00	$9,900,000	No record
Northpond Ventures IIIOther	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/12	450,000 sh	$22.00	$9,900,000	No record
Northpond Ventures III GPOther	Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/12	450,000 sh	$22.00	$9,900,000	No record